Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

[94] F. Chibon, O. Mariani, J. Derré, A. Mairal, J. Coindre, L. Guillou, X. Sastre, F. Pédeutour,
and A. Aurias. Ask1 (map3k5) as a potential therapeutic target in malignant
fibrous histiocytomas with 12q14–q15 and 6q23 amplifications. Genes, Chromosomes
and Cancer, 40(1):32–37, 2004.
[95] S. Chigurupati, R. Venkataraman, D. Barrera, A. Naganathan, M. Madan, L. Paul,
J. Pattisapu, G. Kyriazis, K. Sugaya, S. Bushnev, et al. Receptor channel trpc6 is a
key mediator of notch-driven glioblastoma growth and invasiveness. Cancer research,
70(1):418–427, 2010.
[96] E. Chiocca. The many functions of microRNAs in glioblastoma. World neurosurgery,
2010.
[97] S. Chirasani, A. Sternjak, P. Wend, S. Momma, B. Campos, I. Herrmann, D. Graf,
T. Mitsiadis, C. Herold-Mende, D. Besser, et al. Bone morphogenetic protein-7 release
from endogenous neural precursor cells suppresses the tumourigenicity of stem-like
glioblastoma cells. Brain, 133(7):1961–1972, 2010.
[98] M. Choi, U. Scholl, W. Ji, T. Liu, I. Tikhonova, P. Zumbo, A. Nayir, A. Bakkaloğlu,
S. Özen, S. Sanjad, et al. Genetic diagnosis by whole exome capture and massively parallel
dna sequencing. Proceedings of the National Academy of Sciences, 106(45):19096–
19101, 2009.
[99] L. M. Chow and S. J. Baker. PTEN function in normal and neoplastic growth. Cancer
letters, 241(2):184–196, Sept. 2006.
[100] L. M. Chow, R. Endersby, X. Zhu, S. Rankin, C. Qu, J. Zhang, A. Broniscer, D. W.
Ellison, and S. J. Baker. Cooperativity within and among Pten, p53, and Rb pathways
induces high-grade astrocytoma in adult brain. Cancer Cell, 19(3):305–16, 2011.
[101] M. J. Clark, N. Homer, B. D. O’Connor, Z. Chen, A. Eskin, H. Lee, B. Merriman, and
S. F. Nelson. U87MG decoded: the genomic sequence of a cytogenetically aberrant
human cancer cell line. PLoS genetics, 6(1):e1000832, 2010.
[102] N. M. Cohen, E. Kenigsberg, and A. Tanay. Primate CpG islands are maintained by
heterogeneous evolutionary regimes involving minimal selection. Cell, 145(5):773–786,
May 2011.
[103] A. Collins, P. Berry, C. Hyde, M. Stower, and N. Maitland. Prospective identification
of tumorigenic prostate cancer stem cells. Cancer research, 65(23):10946, 2005.
[104] V. Collins. Amplified genes in human gliomas. In Seminars in cancer biology, volume 4,
page 27, 1993.
[105] H. Colman, L. Zhang, E. Sulman, J. McDonald, N. Shooshtari, A. Rivera, S. Popoff,
C. Nutt, D. Louis, J. Cairncross, et al. A multigene predictor of outcome in glioblastoma.
Neuro-oncology, 12(1):49–57, 2010.
[106] G. O. Consortium et al. Gene ontology: tool for the unification of biology. Nature
genetics, 25(1):25–29, 2000.
[107] L. Conti, S. M. Pollard, T. Gorba, E. Reitano, M. Toselli, G. Biella, Y. Sun, S. Sanzone,
Q.-L. Ying, E. Cattaneo, and A. Smith. Niche-Independent Symmetrical Self-Renewal
of a Mammalian Tissue Stem Cell. PLoS Biology, 3(9):e283, 2005.
[108] H. Contreras, R. Ledezma, J. Vergara, F. Cifuentes, C. Barra, P. Cabello, I. Gallegos,
B. Morales, C. Huidobro, and E. Castellón. The expression of syndecan-1 and-2
is associated with gleason score and epithelial-mesenchymal transition markers, ecadherin
and β-catenin, in prostate cancer. In Urologic Oncology: Seminars and
Original Investigations, volume 28, pages 534–540. Elsevier, 2010.
[109] A. Coutts, E. MacKenzie, E. Griffith, and D. Black. Tes is a novel focal adhesion
protein with a role in cell spreading. Journal of cell science, 116(5):897–906, 2003.
[110] Y. Cui, J. Wang, X. Zhang, R. Lang, M. Bi, L. Guo, and S. Lu. Ecrg2, a novel
candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly
with metallothionein 2a and links to apoptosis* 1,* 2,* 3. Biochemical and biophysical
research communications, 302(4):904–915, 2003.
[111] M. Cully, H. You, and A. Levine. Beyond PTEN mutations: the PI3K pathway as an
integrator of multiple inputs during tumorigenesis. Nature Reviews Cancer, 2006.